C07D221/08

Methods and systems for wireless to power line communications
12150377 · 2024-11-19 · ·

Methods, systems, and apparatus for monitoring and controlling electronic devices using wired and wireless protocols are disclosed. The systems and apparatus may monitor their environment for signals from electronic devices. The systems and apparatus may take and disambiguate the signals that are received from the devices in their environment to identify the devices and associate control signals with the devices. The systems and apparatus may use communication means to send control signals to the identified electronic devices. Multiple apparatuses or systems may be connected together into networks, including mesh networks, to make for a more robust architecture.

Methods and systems for wireless to power line communications
12150377 · 2024-11-19 · ·

Methods, systems, and apparatus for monitoring and controlling electronic devices using wired and wireless protocols are disclosed. The systems and apparatus may monitor their environment for signals from electronic devices. The systems and apparatus may take and disambiguate the signals that are received from the devices in their environment to identify the devices and associate control signals with the devices. The systems and apparatus may use communication means to send control signals to the identified electronic devices. Multiple apparatuses or systems may be connected together into networks, including mesh networks, to make for a more robust architecture.

Organic electroluminescent material and organic optoelectronic device

A compound and an organic optoelectronic device are provided. The compound has the following chemical formula (I): ##STR00001##
chemical formula (I). In the chemical formula (I), X.sub.1 to X.sub.2 are independently selected from O, S, ##STR00002##
and substituted or unsubstituted methylene, and a substituent is selected from hydrogen, deuterium, C.sub.1 to C.sub.30 alkyl, C.sub.1 to C.sub.30 heteroatom-substituted alkyl, C.sub.6 to C.sub.30 aryl, and C.sub.2 to C.sub.30 heteroaryl. X.sub.3 is selected from O, S, substituted or unsubstituted methylene, substituted or unsubstituted methylene, and substituted or unsubstituted silylene, and a substituent is selected hydrogen, deuterium, C.sub.1 to C.sub.30 alkyl, C.sub.1 to C.sub.30 heteroatom-substituted alkyl, C.sub.6 to C.sub.30 aryl, and C.sub.2 to C.sub.30 heteroaryl. R.sub.1 to R.sub.17 are independently selected from hydrogen, deuterium, C.sub.1 to C.sub.30 alkyl, C.sub.1 to C.sub.30 heteroatom-substituted alkyl, C.sub.6 to C.sub.30 aryl, and C.sub.2 to C.sub.30 heteroaryl.

Organic electroluminescent material and organic optoelectronic device

A compound and an organic optoelectronic device are provided. The compound has the following chemical formula (I): ##STR00001##
chemical formula (I). In the chemical formula (I), X.sub.1 to X.sub.2 are independently selected from O, S, ##STR00002##
and substituted or unsubstituted methylene, and a substituent is selected from hydrogen, deuterium, C.sub.1 to C.sub.30 alkyl, C.sub.1 to C.sub.30 heteroatom-substituted alkyl, C.sub.6 to C.sub.30 aryl, and C.sub.2 to C.sub.30 heteroaryl. X.sub.3 is selected from O, S, substituted or unsubstituted methylene, substituted or unsubstituted methylene, and substituted or unsubstituted silylene, and a substituent is selected hydrogen, deuterium, C.sub.1 to C.sub.30 alkyl, C.sub.1 to C.sub.30 heteroatom-substituted alkyl, C.sub.6 to C.sub.30 aryl, and C.sub.2 to C.sub.30 heteroaryl. R.sub.1 to R.sub.17 are independently selected from hydrogen, deuterium, C.sub.1 to C.sub.30 alkyl, C.sub.1 to C.sub.30 heteroatom-substituted alkyl, C.sub.6 to C.sub.30 aryl, and C.sub.2 to C.sub.30 heteroaryl.

LIGHT EMISSION MATERIAL AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME
20240431204 · 2024-12-26 ·

A light emission material includes a first compound satisfying Equation 1:

[00001] K 2 0.1 K 1. Equation 1 In Equation 1, K1 is a sum of radiationless transition rate due to internal conversion from a certain specific n-th triplet excitation state to a lower order triplet excitation state including the lowest triplet excitation state, K2 is a reverse intersystem crossing transition rate from the certain specific n-th triplet excitation state to a singlet excitation state which is adjacent to the n-th triplet excitation state, and n is an integer of 2 or more. An organic electroluminescence device including the light emission material may simultaneously attain high emission efficiency and roll-off reduction.

LIGHT EMISSION MATERIAL AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME
20240431204 · 2024-12-26 ·

A light emission material includes a first compound satisfying Equation 1:

[00001] K 2 0.1 K 1. Equation 1 In Equation 1, K1 is a sum of radiationless transition rate due to internal conversion from a certain specific n-th triplet excitation state to a lower order triplet excitation state including the lowest triplet excitation state, K2 is a reverse intersystem crossing transition rate from the certain specific n-th triplet excitation state to a singlet excitation state which is adjacent to the n-th triplet excitation state, and n is an integer of 2 or more. An organic electroluminescence device including the light emission material may simultaneously attain high emission efficiency and roll-off reduction.

Compounds and Pharmaceutical Compositions Comprising Inhibitors of Amyloid Peptide Interactions with Glycosaminoglycans, Methods of Treatment and Use Thereof
20240398783 · 2024-12-05 ·

The disclosure provides quinoline and quinazoline derivative compounds and pharmaceutical compositions thereof. These compounds inhibit the interactions between GAG-binding amyloid peptides (GBAPs) and heparan sulfate glycosaminoglycans (HS-GAGs) and thus may be useful as therapeutics for the treatment and prevention of neurodegenerative diseases associated with amyloidosis, for example Alzheimer's Disease, and for other amyloid disorders. The present disclosure further provides methods of treatment and prevention of neurodegenerative and amyloid diseases, and methods for identifying small organic molecule compounds that can inhibit the interaction of glycosaminoglycans (GAGs) with GAG-binding amyloid peptides (GBAPs).

Light emission material and organic electroluminescence device including the same
12268088 · 2025-04-01 · ·

A light emission material includes a first compound satisfying Equation 1:
K20.1K1.Equation 1
In Equation 1, K1 is a sum of radiationless transition rate due to internal conversion from a certain specific n-th triplet excitation state to a lower order triplet excitation state including the lowest triplet excitation state, K2 is a reverse intersystem crossing transition rate from the certain specific n-th triplet excitation state to a singlet excitation state which is adjacent to the n-th triplet excitation state, and n is an integer of 2 or more. An organic electroluminescence device including the light emission material may simultaneously attain high emission efficiency and roll-off reduction.

Light emission material and organic electroluminescence device including the same
12268088 · 2025-04-01 · ·

A light emission material includes a first compound satisfying Equation 1:
K20.1K1.Equation 1
In Equation 1, K1 is a sum of radiationless transition rate due to internal conversion from a certain specific n-th triplet excitation state to a lower order triplet excitation state including the lowest triplet excitation state, K2 is a reverse intersystem crossing transition rate from the certain specific n-th triplet excitation state to a singlet excitation state which is adjacent to the n-th triplet excitation state, and n is an integer of 2 or more. An organic electroluminescence device including the light emission material may simultaneously attain high emission efficiency and roll-off reduction.

NOVEL NITROGEN-CONTAINING HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF

The present invention relates to compounds suitable for use in mediating hypoxia inducible factor and for treating erythropoietin-associated conditions by increasing endogenous erythropoietin in vitro and in vivo.